Project Grant HT94252410631
Award Date
8/1/24
Completion Date
7/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cold Spring Harbor, NY 11724, USA
Similar Awards
The federal Project Grant award of $1,224,997.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cold Spring Harbor Laboratory (CSHL) to conduct research aimed at "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." This grant, with a performance period from August 1, 2024 to July 31, 2028, will allow CSHL, a renowned non-profit research institution, to leverage its expertise in cancer biology, genomics,...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...
This federal Project Grant award, valued at $728,450.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to support research conducted by the Cold Spring Harbor Laboratory (CSHL) in Cold Spring Harbor, NY. The purpose of the award is to investigate "COMMUNICATION BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND NEURONS PROMOTES PANCREATIC CANCER PROGRESSION", with a performance period from July 1, 2025 through June 30, 2028....
The U.S. Department of the Army Medical Command awarded a $518,342 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) for a 3-year period from July 1, 2025 to June 30, 2028. The grant supports research investigating "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." CSHL, a non-profit research institution, will conduct advanced scientific investigations...
The Department of the Army Medical Command awarded $1,394,002 to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2022 for a project grant with a completion date of August 14, 2025. Under this award, Cold Spring Harbor Laboratory and sub-awardees Weill Medical College of Cornell University will explore the relationship between sites of metastatic prostate cancer and the peripheral nerve system. Researchers will analyze human...
The Department of the Army Medical Command has awarded a $1,440,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) for the project "TARGETING HYPOTHALAMIC NEURONS TO ABROGATE STRESS-INDUCED BREAST CANCER GROWTH". The grant period runs from March 1, 2025 to February 29, 2028. Through this award, CSHL will conduct advanced biomedical research focused on transforming healthcare for military service members...
The Department of Defense's Defense Health Agency awarded a $2,212,500 Project Grant to the Sloan-Kettering Institute for Cancer Research (MSKCC) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2023, supports a 4-year research project to define the genetic determinants of head and neck cancer progression and immune evasion through computational and functional investigation. The research aims to advance scientific understanding and...
This $2,112,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the Fred Hutchinson Cancer Center in Seattle, Washington to prevent liver metastasis by defining regulators of tumor dormancy, understanding how they are disrupted, and developing strategies to reverse it. The research aims to transform healthcare for military service members and the broader public through innovative and impactful...
Sloan-Kettering Institute For Cancer Research was awarded a $707,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding and overcoming treatment resistance in MDM2-amplified esophageal cancers. The three-year award running from April 1, 2023 to March 31, 2026 will support the Institute's investigation into medical solutions for esophageal cancer on the battlefield by developing strategies...
The Department of the Army Medical Command awarded a $576,001 Project Grant to Cold Spring Harbor Laboratory to support research titled "Role of the Tumor Neuroenvironment in Prostate Cancer Metastasis." The two-year award running from August 1, 2022 to July 31, 2024 will fund research investigating the role of the tumor microenvironment in prostate cancer metastasis. This award is being made under the Military Medical Research and Development program (CFDA 12.420). This program...